Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γ1 and PLC-γ2 in natural killer cells

ISSN: 00221007
134Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Crosslinking of the low affinity immunoglobulin G (IgG) Fc receptor (Fcγ type III) on natural killer (NK) cells initiates antibody-dependent cellular cytotoxicity. During this process, FcγR stimulation results in the rapid activation of phospholipase C (PLC), which hydrolyzes membrane phosphoinositides, generating inositol-1,4,5-trisphosphate and sn-1,2-diacylglycerol as second messengers. We have recently reported that PLC activation after FcγR stimulation can be inhibited by a protein tyrosine kinase (PTK) inhibitor. Based on the paradigm provided by the receptor tyrosine kinases, we investigated whether PLC-γ1 and/or PLC-γ2 are expressed in NK cells, and whether the PLC-γ isoforms are tyrosine phosphorylated in response to FcγR stimulation. Immunoblotting analyses with PLC-γ1- and PLC-γ2-specific antisera demonstrate that both isoforms are expressed in human NK cells. Furthermore, FcγR crosslinking triggers the tyrosine phosphorylation of both PLC-γ1 and PLC-γ2 in these cells. Phosphorylation of both isoforms is detectable within 1 min, and returns to basal level within 30 min. Pretreatment with herbimycin A, a PTK inhibitor, blocked the FcγR-induced tyrosine phosphorylation of PLC-γ1 and PLC-γ2, and the subsequent release of inositol phosphates. These results suggest that FcγR-initiated phosphoinositide turnover in human NK cells is regulated by the tyrosine phosphorylation of PLC-γ. More broadly, these observations demonstrate that nonreceptor PTK(s) activated by crosslinkage of a multisubunit receptor can phosphorylate both PLC-γ isoforms.

Cite

CITATION STYLE

APA

Ting, A. T., Karnitz, L. M., Schoon, R. A., Abraham, R. T., & Leibson, P. J. (1992). Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γ1 and PLC-γ2 in natural killer cells. Journal of Experimental Medicine, 176(6), 1751–1755.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free